Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Alterations in NSCLC: Prognostic Implications and Impact on Therapeutic Resistance.

American journal of clinical oncology - 1 Sept 2026

Neelesh Bhardwaj Tina, Bhardwaj Kanchan, Mn Phani, Padhiar Chirayu

Abstract excerpt

Worldwide, the incidence of lung cancer is projected to continue its upward trend, with an estimated 2.5 million new cases annually. Non-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer, accounting for ~85% of all cases. One of the challenges associated with NSCLC management is incomplete understanding of the underlying molecular mechanisms. Tumors often harbor multiple genetic changes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Epigenesis, Genetic

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 41430544
DOI: 10.1097/COC.0000000000001289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 17 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Alterations in NSCLC: Prognostic Implications and Impact on Therapeutic Resistance.PMID 41430544Read ↗

Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung CancerSemantic proximity Read ↗

NSCLC: An Update of Driver Mutations, Their Role in Pathogenesis and Clinical Significance.Semantic proximity Read ↗

Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.Semantic proximity Read ↗

Oncogenic alterations in advanced NSCLC: a molecular super-highwaySemantic proximity Read ↗

Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacySemantic proximity Read ↗

Molecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Semantic proximity Read ↗

Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges.Semantic proximity Read ↗

Genomic aberrations in non- small cell lung cancer and their impact on treatment outcome.Semantic proximity Read ↗

Molecular Targets Beyond the Big 3.Semantic proximity Read ↗

Genetic and epigenetic changes in lung carcinoma and their clinical implications.Semantic proximity Read ↗

Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future DirectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.